NCT01798004
Clinical Trial Information
Trial Number: NCT01798004 (ClinicalTrials.gov)
Disease Type:
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
Trial Title:
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma
Study ID:
ANBL12P1
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®